Clinical Trials

Colorectal Neoplasms

NCT04844385 2024-02-09

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

124 enrolled

Esophageal Squamous Cell Carcinoma

NCT05580445 2023-11-22

Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

114 enrolled

Advanced Pancreatic Cancer

NCT06078982 2023-10-12

Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer

Phase 1 Unknown

39 enrolled

Stomach Neoplasms

NCT05994456 2023-08-16

Neoadjuvant Toripalimab for dMMR/MSI-H Gastric Cancer

24 enrolled

Stomach Neoplasms

NCT04135690 2023-08-15

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

60 enrolled

Carcinoma, Hepatocellular

NCT04653480 2023-07-17

Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

61 enrolled

Colorectal Neoplasms

NCT04010071 2023-03-29

Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors

60 enrolled

Biliary Tract Neoplasms, Liver Neoplasms

NCT04211168 2023-03-29

Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT04368078 2023-03-29

Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma

76 enrolled

Carcinoma, Hepatocellular

NCT05763927 2023-03-10

Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT

Rectal Neoplasms

NCT05163483 2023-03-06

Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer

87 enrolled

Esophageal Squamous Cell Carcinoma

NCT05350943 2022-10-18

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

70 enrolled

Biliary Tract Adenocarcinoma

NCT03864211 2022-09-29

Thermal Ablation Followed by Immunotherapy for HCC

145 enrolled

Carcinoma, Hepatocellular

NCT05493332 2022-08-18

HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

93 enrolled

Carcinoma, Hepatocellular

NCT05461235 2022-07-18

Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma

1 enrolled

PD-1 Antibody

NCT05448183 2022-07-07

An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma

45 enrolled

Cholangiocarcinoma

NCT04119622 2022-03-11

Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

30 enrolled

Stomach Neoplasms

NCT05173142 2022-03-08

HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors

141 enrolled

Stomach Neoplasms

NCT05240404 2022-02-15

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

116 enrolled

Carcinoma, Hepatocellular

NCT05233358 2022-02-10

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

Phase NA Unknown

176 enrolled

Carcinoma, Hepatocellular

NCT04177797 2022-02-09

Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

20 enrolled

Esophageal Squamous Cell Carcinoma

NCT05162898 2022-01-27

Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.

Phase NA Unknown

90 enrolled

Liver Neoplasms

NCT02915432 2021-12-13

The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC

GastrointestinalHead & Neck

401 enrolled 1 FDA

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Esophageal Squamous Cell Carcinoma

NCT05056337 2021-09-24

Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC

Phase 3 Unknown

220 enrolled

Carcinoma, Hepatocellular

NCT04988191 2021-08-03

Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer

Colorectal Neoplasms

NCT04880811 2021-07-13

Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification

43 enrolled

Esophageal Squamous Cell Carcinoma

NCT04926532 2021-06-15

Toripalimab

30 enrolled

Carcinoma, Hepatocellular

NCT04819516 2021-03-29

Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer

Phase 1 Unknown

10 enrolled

Colorectal Neoplasms

NCT04563975 2021-03-17

Efficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric Cancer

54 enrolled

Stomach Neoplasms

NCT04771715 2021-02-25

Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer

Unknown

100 enrolled

Advanced Colorectal Carcinoma

NCT04170179 2021-02-23

Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis

25 enrolled

Carcinoma, Hepatocellular

NCT04354662 2021-02-18

Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer

35 enrolled

Stomach Neoplasms

NCT04711434 2021-01-20

PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients

Phase 3 Unknown

260 enrolled

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT04644250 2020-11-25

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

32 enrolled

Esophageal Squamous Cell Carcinoma

NCT04437212 2020-06-26

Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer

20 enrolled

Advanced Esophageal Squamous Cell Cancer

NCT04443036 2020-06-23

Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma

Phase NA Unknown

Stomach Neoplasms

NCT04389151 2020-05-15

Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer

30 enrolled

Locally Advanced Colon Cancer

NCT04229849 2020-01-18

Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell Carcinoma

164 enrolled

Esophageal Squamous Cell Carcinoma

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

NCT04069949 2019-10-25

STUHCCPVTT

39 enrolled

Liver Neoplasms

NCT04061928 2019-08-20

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

45 enrolled

PD-1

NCT03927898 2019-04-25

Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis

40 enrolled

Colorectal Neoplasms

NCT03811379 2019-01-23

Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy

43 enrolled